Drug news
Quartette (Teva) is FDA filed for Contraception
Teva Women�s Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd, has announced that the FDA has accepted for filing its New Drug Application (NDA) for Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for Contraception.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.